Literature DB >> 16940

Aminoglycoside antibiotics and renal function: changes in urinary gamma-glutamyltransferase excretion.

P R Beck, R B Thomson, A K Chaudhuri.   

Abstract

The urinary excretion of the renal proximal tubular enzyme, gamma-glutamyltransferase (gamma-GT), has been studied in 41 patients receiving tobramycin, gentamicin or streptomycin for a variety of infections. All patients receiving tobramycin or gentamicin have shown increased excretion of gamma-GT in the urine. Only 46% of those receiving streptomycin have shown an increase in gamma-GT excretion and this is of a lesser degree. A change in creatinine clearance which could only be explained by antibiotic administration was detected in three patients (2 on gentamicin, 1 on streptomycin). The degree of elevation of urinary gamma-GT activity was greater when the initial creatinine clearance was lower, and it is therefore suggested that those patients with pre-existing renal dysfunction should be monitored particularly carefully for signs of nephrotoxicity from these antibiotics. Urinary gamma-GT is a useful enzyme in the investigation of renal drug effects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16940      PMCID: PMC476435          DOI: 10.1136/jcp.30.5.432

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Effect of tobramycin on urinary gamma-glutamyltransferase activity: Studies in a case of renal carcinoma.

Authors:  P R Beck; A K Chaudhuri
Journal:  Clin Chem       Date:  1976-04       Impact factor: 8.327

2.  Nephrotoxicity of combined cephalothin-gentamicin regimen.

Authors:  F Cabanillas; R C Burgos; C Rodríguez; C Baldizón
Journal:  Arch Intern Med       Date:  1975-06

3.  Acute renal failure after high doses of gentamicin and cephalothin.

Authors:  D Kleinknecht; D Ganeval; D Droz
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

4.  Nephrotoxicity of aminoglycosides and gentamicin.

Authors:  F G Falco; H M Smith; G M Arcieri
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

5.  Renal failure and interstitial nephritis due to penicillin and methicillin.

Authors:  D S Baldwin; B B Levine; R T McCluskey; G R Gallo
Journal:  N Engl J Med       Date:  1968-12-05       Impact factor: 91.245

6.  Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension.

Authors:  D J Warren; C P Swainson; N Wright
Journal:  Br Med J       Date:  1974-04-27

7.  Evidence of gentamicin nephrotoxicity in patients with renal allografts.

Authors:  J M Wellwood; P M Simpson; J R Tighe; A E Thompson
Journal:  Br Med J       Date:  1975-08-02

8.  Renal damage caused by gentamicin: a study of the effects on renal morphology and urinary enzyme excretion.

Authors:  J M Wellwood; D Lovell; A E Thompson; J R Tighe
Journal:  J Pathol       Date:  1976-03       Impact factor: 7.996

9.  Acute renal failure associated with combined gentamicin and cephalothin therapy.

Authors:  J P Fillastre; R Laumonier; G Humbert; D Dubois; J Metayer; A Delpech; J Leroy; M Robert
Journal:  Br Med J       Date:  1973-05-19

10.  Comparative clinical study of tobramycin and gentamicin.

Authors:  J Klastersky; C Hensgens; A Henri; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

View more
  3 in total

Review 1.  Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?

Authors:  M L Barclay; C M Kirkpatrick; E J Begg
Journal:  Clin Pharmacokinet       Date:  1999-02       Impact factor: 6.447

Review 2.  [Tobramycin concentrations in human renal tissue (author's transl)].

Authors:  O Brückner; U Kroening; R Nagel
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Polyphenolic fraction of Algerian propolis protects rat kidney against acute oxidative stress induced by doxorubicin.

Authors:  K Boutabet; W Kebsa; M Alyane; M Lahouel
Journal:  Indian J Nephrol       Date:  2011-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.